Cargando…
A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)
PURPOSE: We aimed to develop a combined predicting model for benign esophageal stenosis (BES) after simultaneous integrated boost (SIB) with concurrent chemotherapy in patients with esophageal squamous cell carcinoma (ESCC). METHODS: This study included 65 patients with EC who underwent SIB with che...
Autores principales: | Liu, Weitong, Zeng, Chengbing, Wang, Siyan, Zhan, Yizhou, Huang, Ruihong, Luo, Ting, Peng, Guobo, Wu, Yanxuan, Qiu, Zihan, Li, Derui, Wu, Fangcai, Chen, Chuangzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107369/ https://www.ncbi.nlm.nih.gov/pubmed/37078004 http://dx.doi.org/10.3389/fonc.2022.1026305 |
Ejemplares similares
-
Distribution of Peripheral Blood Cells in Esophageal Cancer Patients During Concurrent Chemoradiotherapy Predicts Long-Term Locoregional Progression Hazard After Treatment (GASTO1072)
por: Xu, Liangyu, et al.
Publicado: (2021) -
Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089)
por: Peng, Guobo, et al.
Publicado: (2022) -
Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study
por: Chen, Chuangzhen, et al.
Publicado: (2021) -
Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy
por: Zeng, Chengbing, et al.
Publicado: (2021) -
Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal Carcinoma
por: Huang, Ruihong, et al.
Publicado: (2020)